Latest:
Advances in Radiation Improve Precision in Brain Cancer Therapy
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
- About Us
- Advertise / Support
- Editorial Board
- Contact Us
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
- Washington My Health My Data
© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Contributors
Dr. Daniel J. Boffa
Dr. Daniel J. Boffa is a professor of thoracic surgery at Yale School of Medicine.
Latest:
Understanding That Not All Lung Cancer Cases Are Linked to Smoking
In honor of Lung Cancer Awareness Month, CURE spoke with Dr. Daniel J. Boffa about how the understanding of lung cancer is evolving beyond smoking.
Dr. Ioana Bonta
Dr. Ioana Bonta is a a board-certified physician in medical oncology and internal medicine. She serves as an adjunct clinical assistant professor at Morehouse School of Medicine, Northside Hospital Cancer Institute, Georgia Cancer Specialists.
Latest:
Why It’s Important to Know That "Lung Cancer Can Affect Everybody"
In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’
Dr. David A. Braun
Dr. David A. Braun is an Assistant Professor of Medicine (Medical Oncology) and a Louis Goodman and Alfred Gilman Yale Scholar, at Yale School of Medicine, and a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center, New Haven, Connecticut.
Latest:
Investigating Personalized Vaccine Use in Kidney Cancer Care
Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the investigation is still in early stages.
Dr. Gabriel A. Brooks
Dr. Gabriel A. Brooks Brooks currently serves as an associate professor of medicine and an associate professor of The Dartmouth Institute, Dartmouth Cancer Center, The Dartmouth Institute for Health Policy and Clinical Practice. He is also a member of the Cancer Population Sciences Research Program, and a member of the Gastrointestinal Clinical Oncology Group, at Dartmouth Geisel School of Medicine, in Lebanon, New Hampshire.
Latest:
What Patients With Cancer Should Know About DPD Deficiency Prior to Chemo
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it.